Published in Breast Cancer Res Treat on September 15, 2005
Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. JAMA (2011) 16.68
Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial. Lancet Oncol (2014) 6.09
Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial. Lancet Oncol (2010) 4.81
Health-related quality of life in breast cancer patients: a bibliographic review of the literature from 1974 to 2007. J Exp Clin Cancer Res (2008) 2.94
Lymphedema in breast cancer survivors: incidence, degree, time course, treatment, and symptoms. J Clin Oncol (2008) 2.81
Morbidity results from the NSABP B-32 trial comparing sentinel lymph node dissection versus axillary dissection. J Surg Oncol (2010) 2.52
Critical research gaps and translational priorities for the successful prevention and treatment of breast cancer. Breast Cancer Res (2013) 1.92
Risk factors for lymphedema after breast cancer treatment. Cancer Epidemiol Biomarkers Prev (2010) 1.90
Patient-reported outcomes in sentinel node-negative adjuvant breast cancer patients receiving sentinel-node biopsy or axillary dissection: National Surgical Adjuvant Breast and Bowel Project phase III protocol B-32. J Clin Oncol (2010) 1.54
Minimal limb volume change has a significant impact on breast cancer survivors. Lymphology (2009) 1.46
Elaboration of a nomogram to predict nonsentinel node status in breast cancer patients with positive sentinel node, intraoperatively assessed with one step nucleic amplification: Retrospective and validation phase. J Exp Clin Cancer Res (2016) 1.39
A contemporary, population-based study of lymphedema risk factors in older women with breast cancer. Ann Surg Oncol (2009) 1.27
Interdisciplinary GoR level III Guidelines for the Diagnosis, Therapy and Follow-up Care of Breast Cancer: Short version - AWMF Registry No.: 032-045OL AWMF-Register-Nummer: 032-045OL - Kurzversion 3.0, Juli 2012. Geburtshilfe Frauenheilkd (2013) 1.14
A further survey of surgical management of the axilla in UK breast cancer patients. Ann R Coll Surg Engl (2010) 1.09
Breast Cancer: State of the Art and New Findings. Geburtshilfe Frauenheilkd (2012) 1.01
The treatment of early breast cancer in women over the age of 70. Br J Cancer (2011) 0.95
Extent of primary breast cancer surgery: standards and individualized concepts. Breast Care (Basel) (2012) 0.95
Can the sentinel lymph node technique affect decisions to offer internal mammary chain irradiation? Eur J Nucl Med Mol Imaging (2009) 0.94
Local treatment of the axilla in early breast cancer: concepts from the national surgical adjuvant breast and bowel project B-04 to the planned intergroup sentinel mamma trial. Breast Care (Basel) (2014) 0.93
Quality of life after sentinel lymph node biopsy or axillary lymph node dissection in stage I/II breast cancer patients: a prospective longitudinal study. Ann Surg Oncol (2008) 0.92
A randomized trial of exercise on well-being and function following breast cancer surgery: the RESTORE trial. J Cancer Surviv (2011) 0.92
Effects of manual lymphatic drainage on breast cancer-related lymphedema: a systematic review and meta-analysis of randomized controlled trials. World J Surg Oncol (2013) 0.91
Chronic preoperative pain and psychological robustness predict acute postoperative pain outcomes after surgery for breast cancer. Br J Cancer (2012) 0.91
Older breast cancer survivors: factors associated with self-reported symptoms of persistent lymphedema over 7 years of follow-up. Breast J (2009) 0.90
Symptom report in detecting breast cancer-related lymphedema. Breast Cancer (Dove Med Press) (2015) 0.90
Prevention of nodal metastases in breast cancer following the lymphatic migration of paclitaxel-loaded expansile nanoparticles. Biomaterials (2012) 0.89
Quantitative molecular analysis of sentinel lymph node may be predictive of axillary node status in breast cancer classified by molecular subtypes. PLoS One (2013) 0.87
Landmark trials affecting the surgical management of invasive breast cancer. Surg Clin North Am (2013) 0.85
Value of sentinel node status as a prognostic factor in melanoma: prospective observational study. BMJ (2006) 0.84
Sentinel node biopsy and axillary dissection in breast cancer: the evidence and its limits. Dtsch Arztebl Int (2014) 0.83
Morbidity after conventional dissection of axillary lymph nodes in breast cancer patients. World J Surg Oncol (2014) 0.83
An intervention to improve communication between breast cancer survivors and their physicians. J Psychosoc Oncol (2010) 0.82
Elaboration of a nomogram to predict non sentinel node status in breast cancer patients with positive sentinel node, intra-operatively assessed with one step nucleic acid amplification method. J Exp Clin Cancer Res (2015) 0.81
Reducing persistent postoperative pain and disability 1 year after breast cancer surgery: a randomized, controlled trial comparing thoracic paravertebral block to local anesthetic infiltration. Ann Surg Oncol (2013) 0.80
Application of intraoperative frozen section examination in the management of female breast cancer in China: a nationwide, multicenter 10-year epidemiological study. World J Surg Oncol (2014) 0.80
Quality of life among a population-based cohort of older patients with breast cancer. Breast (2014) 0.80
Lymphoscintigraphy and triangulated body marking for morbidity reduction during sentinel node biopsy in breast cancer. Int Semin Surg Oncol (2005) 0.80
Sentinel lymph node biopsy at the time of mastectomy does not increase the risk of lymphedema: implications for prophylactic surgery. Breast Cancer Res Treat (2012) 0.80
Axillary Ultrasound Accurately Excludes Clinically Significant Lymph Node Disease in Patients With Early Stage Breast Cancer. Ann Surg (2016) 0.80
Breast cancer metastasis and the lymphatic system. Oncol Lett (2015) 0.79
Older patients with breast cancer: is there bias in the treatment they receive? Ther Adv Med Oncol (2012) 0.78
Utility of sentinel lymph node biopsy for solitary dermal melanomas. J Surg Oncol (2015) 0.78
An improved axillary staging system using the OSNA assay does not modify the therapeutic management of breast cancer patients. Sci Rep (2014) 0.77
Controversial indications for sentinel lymph node biopsy in breast cancer patients. Biomed Res Int (2015) 0.77
Free lymph node flap transfer and laser-assisted liposuction: a combined technique for the treatment of moderate upper limb lymphedema. Lasers Med Sci (2015) 0.76
Current management of the axilla in patients with clinically node-negative breast cancer: a nationwide survey of United Kingdom breast surgeons. Int Semin Surg Oncol (2007) 0.76
Effectiveness and cost-effectiveness of sentinel lymph node biopsy compared with axillary node dissection in patients with early-stage breast cancer: a decision model analysis. Br J Cancer (2012) 0.76
Meta-analytic comparison of randomized and nonrandomized studies of breast cancer surgery. Can J Surg (2012) 0.76
Sentinel lymph node biopsy (SLNB) vs. axillary lymph node dissection (ALND) in the current surgical treatment of early stage breast cancer. J Med Life (2015) 0.75
Sentinel lymph node biopsy under fluorescent indocyanin green guidance: Initial experience. Ulus Cerrahi Derg (2015) 0.75
Trends and controversies in multidisciplinary care of the patient with breast cancer. Curr Probl Surg (2016) 0.75
Imprint cytology predicts axillary node status in sentinel lymph node biopsy. Ulster Med J (2010) 0.75
Relationship between arm morbidity and patient-reported outcomes following surgery in women with node-negative breast cancer: NSABP protocol B-32. J Support Oncol (2013) 0.75
The Feasibility and Accuracy of Sentinel Lymph Node Biopsy in Initially Clinically Node-Negative Breast Cancer after Neoadjuvant Chemotherapy: A Systematic Review and Meta-Analysis. PLoS One (2016) 0.75
Recent perspectives of breast cancer prognosis and predictive factors. Oncol Lett (2016) 0.75
DCIS and axillary nodal evaluation: compliance with national guidelines. BMC Surg (2017) 0.75
The impact of mammographic screening on the surgical management of breast cancer. J Surg Oncol (2016) 0.75
Successful Completion of the Pilot Phase of a Randomized Controlled Trial Comparing Sentinel Lymph Node Biopsy to No Further Axillary Staging in Patients with Clinical T1-T2 N0 Breast Cancer and Normal Axillary Ultrasound. J Am Coll Surg (2016) 0.75
The Relevance of Ultrasound Imaging of Suspicious Axillary Lymph Nodes and Fine-needle Aspiration Biopsy in the Post-ACOSOG Z11 Era in Early Breast Cancer. Acad Radiol (2016) 0.75
Sentinel lymph node biopsy in breast cancer. Saudi Med J (2015) 0.75
Axillary radiotherapy: an alternative treatment option for adjuvant axillary management of breast cancer. Sci Rep (2016) 0.75
Sentinel lymph node biopsy: vision, multicentre trials, professional and technological synergy. Eur J Nucl Med Mol Imaging (2006) 0.75
A grid matrix-based Raman spectroscopic method to characterize different cell milieu in biopsied axillary sentinel lymph nodes of breast cancer patients. Lasers Med Sci (2015) 0.75
A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer. N Engl J Med (2004) 10.41
Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features. Proc Natl Acad Sci U S A (2009) 7.95
Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial. J Natl Cancer Inst (2006) 7.29
Epidemiology and impact of multimorbidity in primary care: a retrospective cohort study. Br J Gen Pract (2011) 6.24
Prognostic value of Ki67 expression after short-term presurgical endocrine therapy for primary breast cancer. J Natl Cancer Inst (2007) 4.46
Phase II randomized study of neoadjuvant everolimus plus letrozole compared with placebo plus letrozole in patients with estrogen receptor-positive breast cancer. J Clin Oncol (2009) 4.12
Suppression of plasma estrogen levels by letrozole and anastrozole is related to body mass index in patients with breast cancer. J Clin Oncol (2012) 3.16
Accuracy and surgical impact of magnetic resonance imaging in breast cancer staging: systematic review and meta-analysis in detection of multifocal and multicentric cancer. J Clin Oncol (2008) 3.06
Assessing the quality of decision support technologies using the International Patient Decision Aid Standards instrument (IPDASi). PLoS One (2009) 2.97
International guidelines for management of metastatic breast cancer: combination vs sequential single-agent chemotherapy. J Natl Cancer Inst (2009) 2.77
Optimal uses of antiretrovirals for prevention in HIV-1 serodiscordant heterosexual couples in South Africa: a modelling study. PLoS Med (2011) 2.76
Magnetic resonance imaging of the breast: recommendations from the EUSOMA working group. Eur J Cancer (2010) 2.62
Initial burden of disease estimates for South Africa, 2000. S Afr Med J (2003) 2.56
Short-term changes in Ki-67 during neoadjuvant treatment of primary breast cancer with anastrozole or tamoxifen alone or combined correlate with recurrence-free survival. Clin Cancer Res (2005) 2.42
Early cognitive-behavioural therapy for post-traumatic stress symptoms after physical injury. Randomised controlled trial. Br J Psychiatry (2004) 2.33
Morphologic predictors of lymph node status in rectal cancer with use of high-spatial-resolution MR imaging with histopathologic comparison. Radiology (2003) 2.24
Consensus conference on breast conservation. J Am Coll Surg (2006) 2.17
Tissue type is a major modifier of the 5-hydroxymethylcytosine content of human genes. Genome Res (2011) 2.15
Sentinel node identification rate and nodal involvement in the EORTC 10981-22023 AMAROS trial. Ann Surg Oncol (2010) 2.04
Biomarker changes during neoadjuvant anastrozole, tamoxifen, or the combination: influence of hormonal status and HER-2 in breast cancer--a study from the IMPACT trialists. J Clin Oncol (2005) 2.04
Effects of anastrozole on cognitive performance in postmenopausal women: a randomised, double-blind chemoprevention trial (IBIS II). Lancet Oncol (2008) 2.01
Factors affecting failed localisation and false-negative rates of sentinel node biopsy in breast cancer--results of the ALMANAC validation phase. Breast Cancer Res Treat (2006) 1.95
Meta-analysis of the impact of surgical margins on local recurrence in women with early-stage invasive breast cancer treated with breast-conserving therapy. Eur J Cancer (2010) 1.85
Transcriptionally repressed genes become aberrantly methylated and distinguish tumors of different lineages in breast cancer. Proc Natl Acad Sci U S A (2011) 1.82
The hepatocyte growth factor regulatory factors in human breast cancer. Clin Cancer Res (2004) 1.80
Rasch fit statistics and sample size considerations for polytomous data. BMC Med Res Methodol (2008) 1.77
Prognostic value of rho GTPases and rho guanine nucleotide dissociation inhibitors in human breast cancers. Clin Cancer Res (2003) 1.76
Role of axillary clearance after a tumor-positive sentinel node in the administration of adjuvant therapy in early breast cancer. J Clin Oncol (2009) 1.74
Effect of riboflavin status on the homocysteine-lowering effect of folate in relation to the MTHFR (C677T) genotype. Clin Chem (2003) 1.68
Differential expression of the CCN family members Cyr61, CTGF and Nov in human breast cancer. Endocr Relat Cancer (2004) 1.67
Stromal cell derived factor-1: its influence on invasiveness and migration of breast cancer cells in vitro, and its association with prognosis and survival in human breast cancer. Breast Cancer Res (2005) 1.66
Dynamic changes in gene expression in vivo predict prognosis of tamoxifen-treated patients with breast cancer. Breast Cancer Res (2010) 1.65
Tissue of origin determines cancer-associated CpG island promoter hypermethylation patterns. Genome Biol (2012) 1.63
Estrogen-independent proliferation is present in estrogen-receptor HER2-positive primary breast cancer after neoadjuvant letrozole. J Clin Oncol (2006) 1.62
Recognition and management of treatment-related side effects for breast cancer patients receiving adjuvant endocrine therapy. Breast Cancer Res Treat (2007) 1.61
Detection of PIK3CA mutations in circulating free DNA in patients with breast cancer. Breast Cancer Res Treat (2010) 1.59
Magnetic resonance imaging screening of the contralateral breast in women with newly diagnosed breast cancer: systematic review and meta-analysis of incremental cancer detection and impact on surgical management. J Clin Oncol (2009) 1.58
The role of the CD44/ezrin complex in cancer metastasis. Crit Rev Oncol Hematol (2003) 1.51
Proceedings of the international consensus conference on breast cancer risk, genetics, & risk management, April, 2007. Breast J (2009) 1.48
Increased levels of SPARC (osteonectin) in human breast cancer tissues and its association with clinical outcomes. Prostaglandins Leukot Essent Fatty Acids (2005) 1.46
The learning curve in sentinel node biopsy: the ALMANAC experience. Ann Surg Oncol (2004) 1.44
Expression of peroxisome-proliferator activated receptor-gamma (PPARgamma) and the PPARgamma co-activator, PGC-1, in human breast cancer correlates with clinical outcomes. Int J Cancer (2003) 1.44
What oncologists believe they said and what patients believe they heard: an analysis of phase I trial discussions. J Clin Oncol (2010) 1.41
Levels of expression of endothelial markers specific to tumour-associated endothelial cells and their correlation with prognosis in patients with breast cancer. Clin Exp Metastasis (2004) 1.37
Functional genetic polymorphisms in the aromatase gene CYP19 vary the response of breast cancer patients to neoadjuvant therapy with aromatase inhibitors. Cancer Res (2010) 1.37
Expression of transcription factor CREB1 in human breast cancer and its correlation with prognosis. Oncol Rep (2007) 1.34
Loss of tight junction plaque molecules in breast cancer tissues is associated with a poor prognosis in patients with breast cancer. Eur J Cancer (2004) 1.34
Translation elongation factor eEF1A2 is a potential oncoprotein that is overexpressed in two-thirds of breast tumours. BMC Cancer (2005) 1.33
The expression and prognostic value of ROCK I and ROCK II and their role in human breast cancer. Int J Oncol (2008) 1.32
Molecular response to aromatase inhibitor treatment in primary breast cancer. Breast Cancer Res (2007) 1.31
Morbidity in breast cancer patients with sentinel node metastases undergoing delayed axillary lymph node dissection (ALND) compared with immediate ALND. Ann Surg Oncol (2007) 1.29
Viral load monitoring of antiretroviral therapy, cohort viral load and HIV transmission in Southern Africa: a mathematical modelling analysis. AIDS (2012) 1.26
Pomegranate extracts potently suppress proliferation, xenograft growth, and invasion of human prostate cancer cells. J Med Food (2004) 1.26
The elevated level of CXCR4 is correlated with nodal metastasis of human breast cancer. Breast (2005) 1.24
Expression of membrane type-1 matrix metalloproteinase, MT1-MMP in human breast cancer and its impact on invasiveness of breast cancer cells. Int J Mol Med (2006) 1.21
Fully specified bootstrap confidence intervals for the difference of two independent binomial proportions based on the median unbiased estimator. Stat Med (2009) 1.21
Reduction of isoforms of 15-lipoxygenase (15-LOX)-1 and 15-LOX-2 in human breast cancer. Prostaglandins Leukot Essent Fatty Acids (2006) 1.20
Supporting informed decision making for prostate specific antigen (PSA) testing on the web: an online randomized controlled trial. J Med Internet Res (2010) 1.19
Targeting matrilysin and its impact on tumor growth in vivo: the potential implications in breast cancer therapy. Clin Cancer Res (2005) 1.15
Levels of expression of lipoxygenases and cyclooxygenase-2 in human breast cancer. Prostaglandins Leukot Essent Fatty Acids (2003) 1.14
Gene expression profiles differentiating between breast cancers clinically responsive or resistant to letrozole. J Clin Oncol (2009) 1.14
Role of routine preoperative lymphoscintigraphy in sentinel node biopsy for breast cancer. Eur J Cancer (2005) 1.14
Proliferation and apoptosis as markers of benefit in neoadjuvant endocrine therapy of breast cancer. Clin Cancer Res (2006) 1.14
PIK3CA genotype and a PIK3CA mutation-related gene signature and response to everolimus and letrozole in estrogen receptor positive breast cancer. PLoS One (2013) 1.12
Tuberin and hamartin are aberrantly expressed and linked to clinical outcome in human breast cancer: the role of promoter methylation of TSC genes. Eur J Cancer (2005) 1.12
Differential expression and prognostic implications of the CCN family members WISP-1, WISP-2, and WISP-3 in human breast cancer. Ann Surg Oncol (2007) 1.12
Pain and health-related quality of life in patients with advanced solid tumours and bone metastases: integrated results from three randomized, double-blind studies of denosumab and zoledronic acid. Support Care Cancer (2013) 1.12
Epidermis instructs skin homing receptor expression in human T cells. Blood (2012) 1.10
A further survey of surgical management of the axilla in UK breast cancer patients. Ann R Coll Surg Engl (2010) 1.09
Skill acquisition and retention in automated external defibrillator (AED) use and CPR by lay responders: a prospective study. Resuscitation (2004) 1.08
Eplin-alpha expression in human breast cancer, the impact on cellular migration and clinical outcome. Mol Cancer (2008) 1.07
Optimal refresher training intervals for AED and CPR skills: a randomised controlled trial. Resuscitation (2006) 1.05
Methylenetetrahydrofolate reductase 677C-->T genotype modulates homocysteine responses to a folate-rich diet or a low-dose folic acid supplement: a randomized controlled trial. Am J Clin Nutr (2002) 1.04
Serum brain-derived neurotrophic factor levels are specifically associated with memory performance among Alzheimer's disease cases. Dement Geriatr Cogn Disord (2010) 1.04
Recent advances in sentinel lymph node biopsy for breast cancer. Curr Opin Oncol (2008) 1.04
Correcting for intra-experiment variation in Illumina BeadChip data is necessary to generate robust gene-expression profiles. BMC Genomics (2010) 1.04
Expression of Placenta growth factor (PlGF) in non-small cell lung cancer (NSCLC) and the clinical and prognostic significance. World J Surg Oncol (2005) 1.03
Diagnostic strategies for autosomal dominant acute porphyrias: retrospective analysis of 467 unrelated patients referred for mutational analysis of the HMBS, CPOX, or PPOX gene. Clin Chem (2009) 1.03
Reliability of the Cardiff Test of basic life support and automated external defibrillation version 3.1. Resuscitation (2003) 1.02
A Rasch and confirmatory factor analysis of the general health questionnaire (GHQ)--12. Health Qual Life Outcomes (2010) 1.02
Breast cancer risk reduction and membrane-bound catechol O-methyltransferase genetic polymorphisms. Cancer Res (2008) 1.02
Expression of interleukin 11 and its receptor and their prognostic value in human breast cancer. Ann Surg Oncol (2006) 1.01
Is there a role of sentinel lymph node biopsy in ductal carcinoma in situ?: analysis of 587 cases. Breast Cancer Res Treat (2006) 1.01
Gene expression profiling of response to mTOR inhibitor everolimus in pre-operatively treated post-menopausal women with oestrogen receptor-positive breast cancer. Breast Cancer Res Treat (2010) 1.00
Work productivity in brain tumor survivors. J Occup Environ Med (2007) 1.00
International expert consensus on primary systemic therapy in the management of early breast cancer: highlights of the Fourth Symposium on Primary Systemic Therapy in the Management of Operable Breast Cancer, Cremona, Italy (2010). J Natl Cancer Inst Monogr (2011) 1.00
Estrogen receptor alpha positive breast tumors and breast cancer cell lines share similarities in their transcriptome data structures. Int J Oncol (2006) 1.00
Expression of autocrine motility factor (AMF) and its receptor, AMFR, in human breast cancer. J Histochem Cytochem (2005) 1.00
Loss of occludin leads to the progression of human breast cancer. Int J Mol Med (2010) 0.99
Fallowfield's Sexual Activity Questionnaire in women with without and at risk of cancer. Menopause Int (2007) 0.99
Biphasic effects of 17-beta-estradiol on expression of occludin and transendothelial resistance and paracellular permeability in human vascular endothelial cells. J Cell Physiol (2003) 0.98
Basics in advanced life support: a role for download audit and metronomes. Resuscitation (2008) 0.98